Bone disease in children with chronic renal failure: therapy with 1alpha-hydroxyvitamin D3
- PMID: 304772
- DOI: 10.1111/j.1365-2265.1977.tb03371.x
Bone disease in children with chronic renal failure: therapy with 1alpha-hydroxyvitamin D3
Abstract
Results of 1alpha-hydroxyvitamin D3 therapy in twelve children with renal bone disease are described. Nine of the twelve children showed a good response to 0.05--0.08 microgram/kg/day. Hypercalcaemia was the only side effect and proved easy to manage because of the short half-life of 1alpha-OHD3.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
